Value and significance of brain radiation therapy during first‐line EGFR‐TKI treatment in lung adenocarcinoma with EGFR sensitive mutation and synchronous brain metastasis: Appropriate timing and technique

Abstract Background For lung adenocarcinoma patients with epidermal growth factor receptor (EGFR) sensitive mutation and synchronous brain metastasis (syn‐BM), when and how to apply radiotherapy (RT) during first‐line tyrosine kinase inhibitor (TKI) treatment remains debatable. Methods From a real‐w...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yangchun Gu, Yan Xu, Hongqing Zhuang, Weijuan Jiang, Hua Zhang, Xiaofeng Li, Yonggang Liu, Li Ma, Dahai Zhao, Yuan Cheng, Yan Yu, Ping Liu, Jianwen Qin, Xueqin Chen, Junzhen Gao, Mengzhao Wang, Li Liang, Baoshan Cao
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	brain metastasis EGFR mutation EGFR‐TKIs lung adenocarcinoma radiation therapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/13557e99f1774b2fab8474230466f55f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Value and significance of brain radiation therapy during first‐line EGFR‐TKI treatment in lung adenocarcinoma with EGFR sensitive mutation and synchronous brain metastasis: Appropriate timing and technique

Ejemplares similares